Biopharma | June 22, 2026
Happiest Health to host Ayurveda & Gut Dialogue on June 29
The event is expected to bring together health and wellness enthusiasts for an afternoon of insights, learning and practical takeaways
The event is expected to bring together health and wellness enthusiasts for an afternoon of insights, learning and practical takeaways
Veteran health innovation and policy leader to drive biotechnology innovation, startup growth and commercialization of indigenous technologies
New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad
Phase 1 study to evaluate Siglec-6-targeted CAR-T therapy in relapsed or refractory AML and CLL patients, marking a major milestone for T-CURX’s scalable non-viral CAR-T platform
Both nations deepen cooperation in health innovation, AI-driven healthcare, biomedical research, data sharing, and life sciences to accelerate next-generation healthcare solutions
Approval is based on results from the phase 3 OASIS 4 clinical trial
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines
Pharma industry veteran brings extensive experience in commercial strategy, business growth, and market leadership to his expanded role at Cipla
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
